An evaluation of chemotherapy in patients with cancer of the cervix and lymph node metastases
- 19 Downloads
During the past twelve years, out of the 288 cervical cancer patients who had lymph node involvement, the recurrence rate in the lymph node, was 26.6% if one or two nodes were involved and 50.8% if three or more nodes were involved (P<0.0001). The recurrence rate of patients who received eight intravenous treatments (at monthly intervals) of multi-agent chemotherapy was lower than those who did not receive treatment. Of patients with one or two positive lymph nodes, 114 received treatment while 50 did not; their respective recurrence rates were 19.3% and 42.0%, a statistically significant difference (P<0.025). Of patients with three or more positive lymph nodes, 97 received treatment and 27 did not, their respective recurrence rates, were 46% and 66% (P=0.30) and the difference is not statistically significant. It would seem that multi-agent chemotherapy may reduce the recurrence rate in patients with cancer of the cervix and positive lymph nodes.
Key wordsChemotherapy Cervical cancer Lymph node
- CX CA
Unable to display preview. Download preview PDF.
- 1.Tinga DJ, Timmer PR, Bouma J, Salders JG (1990) Prognostic significance of single versus multiple lymph node metastases in cervical carcinoma stage 1b. Gynecol Oncol 39:1175–1180Google Scholar
- 2.Ng HT, Shyu SK, Chen YK, Yuan CC, Chao KC, Kan YY (1992) A scoring system for predicting recurrence of cervical cancer. Int J Gynecol Cancer 2:75–78Google Scholar
- 3.Noguchi H, Shiozawa L, Yoshikimi S (1987) Pelvic lymph node metastasis of uterine cervical cancer. Gynceol Oncol 27:150–158Google Scholar
- 4.Firedlander M, Kaye SB, Sullian A, Atkinsion K, Elliot P, Coppleson M, Houghton R, Solomon J, Greed D, Russell P, Hudson CN, Langlands AO, Tattersall MAN (1983) Cerevical carcinoma: A drug responsive tumor-experience with combined cisplatin, vinblastin, and bleomycin therapy. Gynecol Oncol 16:275–281Google Scholar
- 5.Wertheim MS, Hakes TB, Dalghestani AN, Nori D, Smith DH, Lewis JL (1985) A pilot study of adjuvant therapy in patients with cervical cancer at high risk of recurrence after radical hysterectomy and pelvic lymphadenectomy. J Chin Oncol 3:912–916Google Scholar
- 6.Ng HT, Kan YY, Chao KC (1987) The outcome of the patients with recurrent cervical carcinoma in terms of lymph node metastasis and treatment. Gynecol Oncol 26:355–363Google Scholar
- 7.Dargent D, Frobert JL, Beau G (1985) V factor (tumor volume) and T factor (FIGO Classification) in the assessment of cervix cancer prognosis: the risk of lymph node spread. Gynecol Oncol 22:15–22Google Scholar
- 8.Larrsen G, Alm P, Gallberg B, Grundsell H (1985) Prognostic factors in early invasive carcinoma of the uterine cervix. Am J Obstet Gynecol 146:145–153Google Scholar
- 9.Burghardt E, Pickel H, Hass J, Lahousen M (1987) Prognostic factors and operation treatment of stage lb or 2b cervical cancer. Am J Obstet Gynecol 156:988–996Google Scholar